Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: The LIFE study

Journal of Hypertension

Volumn 26, Issue 7, 2008, Pages 1472-1476

  Chinali, Marcello ^a,b   De Simone, Giovanni ^a,b   Wachtell, Kristian ^a,c   Gerdts, Eva ^d   Gardin, Julius M ^e   Boman, Kurt ^f   Nieminen, Markku S ^g   Papademetriou, Vasilios ^h   Dahlöf, Björn ⁱ   Devereux, Richard B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF BERGEN   (Norway)

^e ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^f UMEÅ UNIVERSITY   (Sweden)

^g UNIVERSITY OF HELSINKI   (Finland)

^h Affairs Medical Center   (United States)

ⁱ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LOSARTAN;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; BODY MASS; CARDIAC PATIENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE SIZE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART ATRIUM; HEART ATRIUM FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SYSTOLE;

AGED; ATRIAL FUNCTION, LEFT; FEMALE; HEART ATRIA; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SYSTOLE;

EID: 54449089174     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282ff84d7     Document Type: Article

References (27)

1. de Simone G, Greco R, Mureddu G, Romano C, Guida R, Celentano A, Contaldo F. Relation of left ventricular diastolic properties to systolic function in arterial hypertension. Circulation 2000; 101:152-157.
2. Wachtell K, Smith G, Gerdts E, Dahlof B, Nieminen MS, Papademetriou V, et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol 2000; 85:466-472.
3. Hatle L. Doppler echocardiographic evaluation of diastolic function in hypertensive cardiomyopathies. Eur Heart J 1993; 14. (Suppl J):88-94.
4. Thomas JD, Choong CY, Flachskampf FA, Weyman AE. Analysis of the early transmitral Doppler velocity curve: effect of primary physiologic changes and compensatory preload adjustment. J Am Coll Cardiol 1990; 16:644-655.
5. Prioli A, Marino P, Lanzoni L, Zardini P. Increasing degrees of left ventricular filling impairment modulate left atrial function in humans. Am J Cardiol 1998; 82:756-761.
6. Nikitin NP, Witte KK, Thackray SD, Goodge LJ, Clark AL, Cleland JG. Effect of age and sex on left atrial morphology and function. Eur J Echocardiogr 2003; 4:36-42.
7. Mattioli AV,Tarabini Castellani E, Vivoli D, Molinari R, Mattioli G. Atrial ejection force. Findings in healthy subjects. Cardiologia 1995; 40:341-345.
8. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23:1535-1540.
9. Chinali M, de Simone G, Liu JE, Bella JN, Oberman A, Hopkins PN, et al. Left atrial systolic force and cardiac markers of preclinical disease in hypertensive patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Am J Hypertens 2005; 18:899-905.
10. Chinali M, de Simone G, Roman MJ, Bella JN, Liu JE, Lee ET, et al. Leftatrial systolic force and cardiovascular outcome. The Strong Heart Study. Am J Hypertens 2005; 18:1570-1576.
11. Chinali M, de Simone G, Roman MJ, Lee ET, Best LG, Howard BV, Devereux RB. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol 2006; 47:2267-2273.
12. Thomas L. Assessment of atrial function. Heart Lung Circ 2007; 16:234-242.
13. Dahlof B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, et al. Characteristics of 9194. patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension 1998; 32:989-997.
14. Dahlof B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, et al. The losartan intervention for endpoint reduction (LIFE) in hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens 1997; 10:705-713.
15. Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlöf B, Aalto T, et al. Impact of different partition values on prevalence of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000; 35:6-12.
16. Palmieri V, Dahlöf B, DeQuattro V, Sharpe N, Bella JN, de Simone G, et al. Reliability of echocardiographic assessment ofleftventricular structure and function: the PRESERVE study. Prospective randomized study evaluating regression of ventricular enlargement. J Am Coll Cardiol 1999; 34:1625-1632.
17. Devereux RB, Roman MJ. Evaluation of cardiac function and vascular structure and function by echocardiography and other noninvasive techniques. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management, 2nd ed. New York, NY:Raven Press Ltd; 1995. pp. 1969-1985.
18. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
19. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25:1056-1062.
20. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-1558.
21. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37:7-11.
22. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451. [published erratum appears in J Am Coll Cardiol 1994; 24:844]
23. Nakatani S, Masuyama T, Kodama K, Kitabatake A, Fujii K, Kamada T. Value and limitation of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure half-time and the continuity equation methods. Circulation 1988; 77:78-85.
24. Thomas JD, Weyman AE. Doppler mitral pressure half-time: a clinical tool in search of theoretical justification. J Am Coll Cardiol 1987; 10:923-929.
25. Cioffi G, Mureddu GF, Stefenelli C, de Simone G. Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens 2004; 22:1589-1596.
26. Qirko S, Tase M, Lushnjari V, Sinjari T. Left atrial contractility function in hypertension. Arch Mal Coeur Vaiss 1996; 89:1003-1007.
27. Dernellis JM, Vyssoulis GP, Zacharoulis AA, Toutouzas PK. Effects of antihypertensive therapy on left atrial function. J Hum Hypertens 1996; 10:789-794